Center-Authored Papers
Filters: Author is Storer, Barry E [Clear All Filters]
Biomarker Panel for Chronic Graft-Versus-Host Disease.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 34(22):2583-2590. Abstract
.
2016.
.
2017.
Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 22(4):710-716. Abstract
.
2016.
Effect of MHC and non-MHC donor/recipient genetic disparity on the outcome of allogeneic HCT.. Blood. 120(14):2796-2806. Abstract
.
2012.
.
2013.
Number of courses of induction therapy independently predicts outcome after allogeneic transplantation for acute myeloid leukemia in first morphological remission.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 21(2):373-8. Abstract
.
2015.
.
2009.
Design and Validation of an Augmented Hematopoietic Cell Transplantation-Comorbidity Index Comprising Pretransplant Ferritin, Albumin, and Platelet Count for Prediction of Outcomes after Allogeneic Transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 21(8):1418-24. Abstract
.
2015.
IL10 and IL10 receptor gene variation and outcomes after unrelated and related hematopoietic cell transplantation.. Transplantation. 87(5):704-10. Abstract
.
2009.
Adjusted estimates for time-to-event endpoints.. Lifetime data analysis. 14(4):484-95. Abstract
.
2008.
Statistical considerations in studies of late effects in HCT.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 15(1 Suppl):25-8.
.
2009.
Graft-versus-host disease and graft-versus-tumor effects after allogeneic hematopoietic cell transplantation.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(12):1530-8. Abstract
.
2013.
Allogeneic Hematopoietic Cell Transplantation Following Minimal Intensity Conditioning: Predicting Acute Graft-versus-Host Disease and Graft-versus-Tumor Effects.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 19(5):792-8. Abstract
.
2013.
p63 expression in Merkel cell carcinoma predicts poorer survival yet may have limited clinical utility.. American journal of clinical pathology. 140(6):838-44. Abstract
.
2013.
.
2008.
Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 23(16):3819-29. Abstract
.
2005.
Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(30):4912-20. Abstract
.
2008.
Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies.. JAMA : the journal of the American Medical Association. 306(17):1874-83. Abstract
.
2011.
.
2017.
.
2008.
Comorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 25(27):4246-54. Abstract
.
2007.
Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 32(29):3249-56. Abstract
.
2014.
Prolonged responses in patients with MDS and CMML treated with azacitidine and etanercept.. British journal of haematology. 148(6):944-7. Abstract
.
2010.
Anti-thymocyte globulin plus etanercept as therapy for myelodysplastic syndromes (MDS): a phase II study.. British journal of haematology. 149(5):706-10. Abstract
.
2010. Doing Business with Arnold Library
Weintraub Building, B1-010
(206) 667-4314
library@fredhutch.org
More About Arnold Library
Quick Links
- ILLiad/ILL Form
- Journals List
- Ovid - Medline
- Web of Science
- Pubmed
- Libguides
- Library Catalog
- Researcher Profiles
- Library Affiliations & Memberships
- Fred Hutch Papers (Intranet)